reports
New Data Demonstrates Significant Clinical and Quality-of-Life Benefit...
New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the presentation of new clinical data at the American...
Tactile Medical to Present at Upcoming Investor Conferences in June
Tactile Medical to Present at Upcoming Investor Conferences in June MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be participating in two upcoming investor conferences. Tactile Medical is scheduled to present at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 3:20 p.m. CST and at the Jefferies Global Healthcare Conference in New York on Wedne...
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial ...
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Summary & Recent Business Highlights: Total revenue increased 0.3% year-over-year to $61.3 millionGross margin of 74% versus 71% in Q1 2024Net loss of $3.0 million versus $2.2 million in Q1 2024Adjusted EB...
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial...
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025 MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2025 financial results will be released after the market closes on Monday, May 5, 2025. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 5, 2025, to discuss the results of the ...
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare M...
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which is being virtually held from March 17th – 20th. Management will participate in a virtual presentation on Tuesday, March 18th at 12:00 p.m. Eastern Time....
Tactile Systems Technology Inc: 3 directors
Three Directors at Tactile Systems Technology Inc sold after exercising options/sold 36,872 shares at between 14.181USD and 14.511USD. The significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary ...
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year ...
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Summary & Recent Business Highlights: Total revenue increased 10% year-over-year to $85.6 millionGross margin of 75% versus 72% in Q4 2023Net income of $9.7 million versu...
Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financi...
Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025 MINNEAPOLIS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2024 financial results will be released after the market closes on Tuesday, February 18, 2025. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on February 18, 2025, to discu...
Tactile Medical Expands Launch of Nimbl™ to Include Patients with Lowe...
Tactile Medical Expands Launch of Nimbl™ to Include Patients with Lower Extremity Lymphedema Next-Generation Platform Now Available for Both Upper and Lower Extremity Conditions MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that Nimbl, its next-generation pneumatic compression platform, is now commercially available throughout the United States (U.S.) for the treatment of both upper and lower extremity ly...
Tactile Medical Appoints Laura King to Board of Directors
Tactile Medical Appoints Laura King to Board of Directors MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company’s Board of Directors (“Board”) and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025. Ms. King is a seasoned healthcare executive with a proven track record of leadership and developing innovative products that enhance patient car...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
RMAX RE/MAX HOLDINGS INC.
OMER OMEROS CORPORATION
ELMD ELECTROMED
CRS CARPENTER TECHNOLOGY CORPORATION
CEVA CEVA INC.
AAOI APPLIED OPTOELECTRONICS INC.
SLM SLM CORP
UGI UGI CORPORATION
UTI UNIVERSAL TECHNICAL INSTITUTE INC.
MHH MASTECH DIGITAL
KINS KINGSTONE COS. INC.
PTGX PROTAGONIST THERAPEUTICS
TCMD TACTILE SYSTEMS TECHNOLOGY INC.
PDEX PRO-DEX INC.
FRMO FRMO CORPORATION
MMMB MAMAMANCINI'S HOLDINGS INC
REPL REPLIMUNE GROUP
BE BLOOM ENERGY
NEON NEONODE INC.
PWFL POWERFLEET INC
MRBK MERIDIAN
TPL TEXAS PACIFIC LAND CORPORATION
NPCE NEUROPACE INC
PLL PIEDMONT LITHIUM INC
SMR NUSCALE POWER CORP
RDW REDWIRE CORP
LUNR INTUITIVE MACHINES INC
HIPO HIPPO HLDGS INC
WGS GENEDX HOLDINGS CORP.
ASPI ASP ISOTOPES INC
AESI NEW ATLAS HOLDCO INC
NNE NANO NUCLEAR ENERGY
LB LANDBRIDGE COMPANY LLC
FOA FINANCE OF AMERICA COMPANIES INC.
DOGZ DOGNESS INTERNATIONAL CORP
TECX TD GLOBAL TECHNOLOGY LEADERS CAD HEDGED INDEX ETF
AZ A2Z CUST2MATE SOLUTIONS CORP
CDTX CIDARA THERAPEUTICS INC.
Tactile Medical to Present at the Piper Sandler 36th Annual Healthcare...
Tactile Medical to Present at the Piper Sandler 36th Annual Healthcare Conference MINNEAPOLIS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Piper Sandler 36th Annual Healthcare Conference, which is being held at the Lotte New York Palace in New York, NY from December 3rd – 5th. Management will participate in a fireside chat on Tuesday, December 3rd at 10:00 a.m. Central Time. A ...
Tactile Systems Technology, Inc. Reports Third Quarter 2024 Financial ...
Tactile Systems Technology, Inc. Reports Third Quarter 2024 Financial Results Authorizes Share Repurchase Program MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30, 2024 and announced the adoption of a share repurchase program. Third Quarter 2024 Summary & Recent Business Highlights: Total revenue increased 5% year-over-year to $73.1 million Lymphede...
Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial...
Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024 MINNEAPOLIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2024 financial results will be released after the market closes on Monday, November 4, 2024. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on November 4, 2024, to discuss the r...
Tactile Medical Launches Next-Generation Nimbl™ Lymphedema Platform
Tactile Medical Launches Next-Generation Nimbl™ Lymphedema Platform Initial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that Nimbl, its next-generation pneumatic compression platform, is now commercially available throughout the United States for the treatment of upper extremity lymphedema. Nimbl, which is significantly smalle...
UPDATE -- Tactile Medical Announces Positive Clinical Trial Results in...
UPDATE -- Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy Largest U.S. Prospective Clinical Trial Ever Conducted Demonstrated High Compliance with the Flexitouch® System and Significant Improvements Across Study Endpoints MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the publication of a new clinical study in the Journal...
Tactile Medical Announces Positive Clinical Trial Results in Lymphedem...
Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy Largest U.S. Prospective Clinical Trial Ever Conducted Demonstrated High Compliance with the Flexitouch® System and Significant Improvements Across Study Endpoints MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the publication of a new clinical study in the Journal of Vascul...
Tactile Medical Receives PDAC Approval for Nimbl™ Lymphedema Platform
Tactile Medical Receives PDAC Approval for Nimbl™ Lymphedema Platform Next-Generation System Significantly Reduces Device Size and Weight and Enables Integration with Kylee™ Digital App MINNEAPOLIS, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that the Pricing, Data Analysis, and Coding (PDAC) contractor for the Centers for Medicare & Medicaid Services (CMS) has approved the use of Healthcare Common Procedure Coding...
Tactile Systems Technology, Inc. Reports Second Quarter 2024 Financial...
Tactile Systems Technology, Inc. Reports Second Quarter 2024 Financial Results MINNEAPOLIS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights: Total revenue increased 7% year-over-year to $73.2 million Lymphedema product revenue increased 8% year-over-yearAirway clearance product revenue increased 2% year-over-year Net income of $4...
Tactile Medical to Release Second Quarter of Fiscal Year 2024 Financia...
Tactile Medical to Release Second Quarter of Fiscal Year 2024 Financial Results on August 5, 2024 MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2024 financial results will be released after the market closes on Monday, August 5, 2024. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on August 5, 2024, to discuss the resul...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.